Prokidney (PROK) Operating Expenses (2021 - 2026)

Prokidney (PROK) has reported Operating Expenses for 6 consecutive years, with $48.5 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Operating Expenses rose 21.52% year-over-year to $48.5 million in Q2 2026; TTM through Jun 2026 was $178.0 million, a 2.27% decrease from a year earlier, with the FY2025 full-year figure at $165.9 million, down 9.72% from the prior year.
• Operating Expenses was $48.5 million for Q2 2026 at Prokidney, up from $45.2 million in the prior quarter.
• Over five years, Operating Expenses peaked at $66.5 million in Q1 2022 and troughed at $20.7 million in Q2 2022.
• A 5-year average of $41.5 million and a median of $41.2 million in 2023 frame the typical range for Operating Expenses.
• Across the five-year window, Operating Expenses jumped 1282455.0% in 2022 and plunged 38.5% in 2023, its largest moves.
• Over 5 years, Operating Expenses stood at $30.2 million in 2022, then dropped by 19.93% to $24.2 million in 2023, then soared by 113.33% to $51.6 million in 2024, then retreated by 11.72% to $45.6 million in 2025, then climbed by 6.42% to $48.5 million in 2026.
• The last three Operating Expenses figures came in at $48.5 million (Q2 2026), $45.2 million (Q1 2026), and $45.6 million (Q4 2025), per Business Quant data.